AI-based screening with transient elastography is more cost-effective than standard diagnostic approaches in identifying adults at risk for MASLD with advanced fibrosis.
A new ACC/AHA dyslipidemia guideline and editorial argue that guideline development is rigorous but can lag behind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results